Avexxin (private company)

See something wrong or missing? Let us know
Offices:Trondheim
Business model:B2B

Avexxin will provide a new generation of therapeutics treating serious medical conditions associated with chronic inflammatory disorders and specific cancers.

Investors: we tracked 3 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Avexxin

Name Criteria
Sweden Cinclus Pharma
55%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 1
France Pharmedigroup
55%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 1
France Synapse Medicine
55%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 1
Sweden Trialbee
55%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 1
United Kingdom Causaly
55%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 1
France PEP-Therapy
55%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 1
Sweden iCellate
52%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 1
Sweden Pila Pharma
52%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 1
United Kingdom Beckley Psytech
50%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
Denmark Octarine Bio
50%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
Top